Compounds 1-4 were synthesized and investigated for selectivity and potency for the oxytocin receptor (OTR) to determine their viability as radioactive ligands. Binding assays determined 1-4 to have high binding affinity for both the human and rodent OTR and also have high selectivity for the human OTR over human vasopressin V1a receptors (V1aR). Inadequate selectivity for OTR over V1aR was found for rodent receptors in all four compounds. The radioactive (C-11, F-18, and I-125) derivatives of 1-4 were synthesized and investigated for use as autoradiography and positron emission tomography (PET) ligands. Receptor autoradiography performed with [(125)I]1 and [(125)I]2 on rodent brain slices provided the first small molecule radioligand images of the OTR and V1aR. Biodistribution studies determined [(125)I]1 and [(125)I]2 were adequate for in vivo peripheral investigations, but not for central investigations due to low uptake within the brain. A biodistribution study with [(18)F]3 suggested brain uptake occurred slowly over time. PET imaging studies with [(18)F]3 and [(11)C]4 using a rat model provided insufficient uptake in the brain over a 90 and 45 min scan times respectively to merit further investigations in non-human primates.
Compounds 1-4 were synthesized and investigated for selectivity and potency for the oxytocin receptor (n class="Gene">OTR) to determine their viability as radioactive ligands. Binding assays determined 1-4 to have high binding affinity for both the human and rodent OTR and also have high selectivity for the humanOTR over humanvasopressin V1a receptors (V1aR). Inadequate selectivity for OTR over V1aR was found for rodent receptors in all four compounds. The radioactive (C-11, F-18, and I-125) derivatives of 1-4 were synthesized and investigated for use as autoradiography and positron emission tomography (PET) ligands. Receptor autoradiography performed with [(125)I]1 and [(125)I]2 on rodent brain slices provided the first small molecule radioligand images of the OTR and V1aR. Biodistribution studies determined [(125)I]1 and [(125)I]2 were adequate for in vivo peripheral investigations, but not for central investigations due to low uptake within the brain. A biodistribution study with [(18)F]3 suggested brain uptake occurred slowly over time. PET imaging studies with [(18)F]3 and [(11)C]4 using a rat model provided insufficient uptake in the brain over a 90 and 45 min scan times respectively to merit further investigations in non-human primates.
Authors: Wei Lemaire; Julie A O'Brien; Maryann Burno; Ashok G Chaudhary; Dennis C Dean; Peter D Williams; Roger M Freidinger; Douglas J Pettibone; David L Williams Journal: Eur J Pharmacol Date: 2002-08-16 Impact factor: 4.432
Authors: Adriana Alexandre S Tavares; Nicola K Jobson; Deborah Dewar; Andrew Sutherland; Sally L Pimlott Journal: Nucl Med Biol Date: 2011-02-04 Impact factor: 2.408
Authors: Cédric M Hysek; Yasmin Schmid; Linda D Simmler; Gregor Domes; Markus Heinrichs; Christoph Eisenegger; Katrin H Preller; Boris B Quednow; Matthias E Liechti Journal: Soc Cogn Affect Neurosci Date: 2013-10-04 Impact factor: 3.436
Authors: Aaron L Smith; Sara M Freeman; Todd E Barnhart; David H Abbott; Elizabeth O Ahlers; David L Kukis; Karen L Bales; Mark M Goodman; Larry J Young Journal: Bioorg Med Chem Lett Date: 2016-05-07 Impact factor: 2.823